Lysosomal Therapeutics

Its sale to Allergan was called off at the last minute. One year later, a biotech co-founded by Henri Termeer finds a new buyer
Endpoints
Thu, 10/1/20 - 10:01 am
Lysosomal Therapeutics
Allergan
R&D
M&A
Henri Termeer
Bial
Venturing Boldly Into Neuroscience
Forbes
Thu, 09/21/17 - 08:47 am
startups
Neuroscience
Disarm Therapeutics
Rodin Therapeutics
Lysosomal Therapeutics